Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AD-SVF Therapy for Refractory Endometrial Infertility
NCT07230600Phase 1Recruiting
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Nov 2025
- Primary completion
- Dec 2026
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of autologous adipose-derived stromal vascular fraction in infertility, thin endometrium and Intrauterine Adhesions (IUA), sponsored by Nanjing Drum-Tower Hospital. Primary endpoint: Proportion of patients with endometrial thickness of 6 mm or greater at 6 months. Started Nov 2025; status: recruiting.
02
Drugs
autologous adipose-derived stromal vascular fraction
03
Conditions
infertilitythin endometriumIntrauterine Adhesions (IUA)
Beyond the preview
Go deeper on NCT07230600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07230600.